Old Web
English
Sign In
Acemap
>
Paper
>
229 Anti-IGF1R therapy with dalotuzumab is efficacious in a sub-set of KRAS mutant cetuximab refractory CRC models
229 Anti-IGF1R therapy with dalotuzumab is efficacious in a sub-set of KRAS mutant cetuximab refractory CRC models
2010
Sriram Sathyanarayanan
David Watkins
Kara J. Sykes
S. Howard
Erin Valentine
Andrew Bloecher
E.A. Clark
Karl Hsu
David Cunningham
Christopher Winter
Keywords:
Dalotuzumab
Refractory
Pathology
Cetuximab
Insulin-like growth factor 1 receptor
KRAS
Cancer research
Mutant
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]